Cargando…
Longitudinal Numbers-Needed-To-Treat (NNT) for Achieving Various Levels of Analgesic Response and Improvement with Etoricoxib, Naproxen, and Placebo in Ankylosing Spondylitis
BACKGROUND: Clinical analgesic trials typically report response as group mean results. However, research has shown that few patients are average and most have responses at the extremes. Moreover, group mean results do not convey response levels and thus have limited value in representing the benefit...
Autores principales: | Peloso, Paul M, Gammaitoni, Arnold, Smugar, Steven S, Wang, Hongwei, Moore, Andrew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159143/ https://www.ncbi.nlm.nih.gov/pubmed/21767407 http://dx.doi.org/10.1186/1471-2474-12-165 |
Ejemplares similares
-
A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis
por: Balazcs, Eva, et al.
Publicado: (2016) -
Efficacy of etoricoxib for ankylosing spondylitis: A protocol for systematic review of randomized controlled trial
por: Tang, Hua-yu, et al.
Publicado: (2019) -
Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway
por: Jansen, Jeroen P., et al.
Publicado: (2011) -
Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
por: Marcu, Iulia Rahela, et al.
Publicado: (2020) -
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice
por: Moore, R A, et al.
Publicado: (2010)